65
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma

, , , , , & show all
Pages 3623-3630 | Published online: 26 Apr 2019

References

  • Tisdale MJ. Cancer cachexia. Curr Opin Gastroenterol. 2010;26(2):146–151.19918173
  • Andreyev HJ, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998;34(4):503–509.9713300
  • Crosby T, Hurt CN, Falk S, et al. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. Lancet Oncol. 2013;14(7):627–637. doi:10.1016/S1470-2045(13)70136-023623280
  • Cox S, Powell C, Carter B, Hurt C, Mukherjee S, Crosby TD. Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1. Br J Cancer. 2016;115(2):172–177. doi:10.1038/bjc.2016.12927328311
  • Di Fiore A, Lecleire S, Gangloff A, et al. Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer. Dig Liver Dis. 2014;46(3):270–275. doi:10.1016/j.dld.2013.10.01624439424
  • Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive registry of esophageal cancer in Japan, 2010. Esophagus. 2017;14(3):189–214. doi:10.1007/s10388-017-0578-428725168
  • Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48. doi:10.1016/j.clnu.2016.07.01527637832
  • Kato H, Sato A, Fukuda H, et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol. 2009;39(10):638–643. doi:10.1093/jjco/hyp06919549720
  • Sakanaka K, Ishida Y, Itasaka S, et al. Identification of a predictive factor for distant metastasis in esophageal squamous cell carcinoma after definitive chemoradiotherapy. Int J Clin Oncol. 2016;21(5):899–908. doi:10.1007/s10147-016-0967-z26936851
  • Akutsu Y, Kato K, Igaki H, et al. The prevalence of overall and initial lymph node metastases in clinical T1N0 thoracic esophageal cancer: from the results of JCOG0502, a prospective multicenter study. Ann Surg. 2016;264(6):1009–1015.27420375
  • Kato K, Muro K, Minashi K, et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys. 2011;81(3):684–690. doi:10.1016/j.ijrobp.2010.06.03320932658
  • Kato K, Eguchi Nakajima T, Ito Y, et al. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for stage II-III esophageal carcinoma. Jpn J Clin Oncol. 2013;43(6):608–615. doi:10.1093/jjco/hyt04823585687
  • Buzby GP, Knox LS, Crosby LO, et al. Study protocol: a randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Am J Clin Nutr. 1988;47(2 Suppl):366–381. doi:10.1093/ajcn/47.2.3663124598
  • Group TVATPNCS. Perioperative total parenteral nutrition in surgical patients. N Engl J Med. 1991;325(8):525–532. doi:10.1056/NEJM1991082232508011906987
  • Bouillanne O, Morineau G, Dupont C, et al. Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82(4):777–783. doi:10.1093/ajcn/82.4.77716210706
  • Conroy T, Galais MP, Raoul JL, et al. Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial. Lancet Oncol. 2014;15(3):305–314. doi:10.1016/S1470-2045(14)70028-224556041
  • Payakachat N, Ounpraseuth S, Suen JY. Late complications and long-term quality of life for survivors (>5 years) with history of head and neck cancer. Head Neck. 2013;35(6):819–825. doi:10.1002/hed.2303522807083
  • Abdiev S, Kodera Y, Fujiwara M, et al. Nutritional recovery after open and laparoscopic gastrectomies. Gastric Cancer. 2011;14(2):144–149. doi:10.1007/s10120-011-0021-921327442
  • Ito H, Itasaka S, Sakanaka K, Araki N, Mizowaki T, Hiraoka M. Long-term complications of definitive chemoradiotherapy for esophageal cancer using the classical method. J Radiat Res. 2017;58(1):106–113. doi:10.1093/jrr/rrw07827475126
  • Ishida Y, Sakanaka K, Itasaka S, et al. Effect of long fasting on myocardial accumulation in 18F-fluorodeoxyglucose positron emission tomography after chemoradiotherapy for esophageal carcinoma. J Radiat Res. 2018;59(2):182–189. doi:10.1093/jrr/rrx07629281031
  • Aizawa R, Matsumoto S, Uneno Y, et al. Severe esophagitis associated with cytomegalovirus during concurrent chemoradiotherapy for esophageal cancer. Jpn J Clin Oncol. 2017;47(9):885–888. doi:10.1093/jjco/hyx08328591845
  • Laviano A, Meguid MM. Nutritional issues in cancer management. Nutrition. 1996;12(5):358–371.8875522